Abstract
Schriner and colleagues have reported an important advance in our understanding of the mechanisms controlling lifespan in mammalian species. A transgenic mouse strain was constructed(MCAT) with a C57BL/6J background that has about a 50-fold increase in expression in cardiac mitochondria and skeletal muscle of catalase enzyme activity. The MCAT strain was found to have reduced severity of age-dependent arteriosclerosis and increased genomic stability, as indicated by a decrease in oxidative stress and mitochondrial deletions in heart and muscle tissues. Most exciting, however, is that both median and maximum lifespan were increased about 17–21% compared to wild-type controls. It was disappointing that the Gompertz plot of the MCAT strain ran parallel to the wild-type control, indicating a delay in the onset of aging rather than a decrease in aging rate. Nevertheless, these results support the notion of a role for mitochondrial oxidative stress as a determinant of both healthspan and lifespan. In addition, the relatively large increase in lifespan resulting from upregulation of a single gene suggests the possibility that similar upregulation of relatively few key longevity determinant genes may result in dramatic increases in lifespan.
Get full access to this article
View all access options for this article.
